drug promotion

drug promotion

Pharmaceutical industry Any activity–advertising, 'detailing,' 'freebies,' and sponsoring of conferences and symposia–by a drug company which is intended to ↑ the sales of its products
Mentioned in ?
References in periodicals archive ?
Included in Amarin's promotion plans is a direct-to-consumer advertising campaign, subject to review by the FDA's Office of Prescription Drug Promotion, or OPDP.
According to HHS, if a manufacturer simply includes price information in a direct-to-consumer advertisement as required, that information in the advertisement will not require review by the Food and Drug Administration Office of Prescription Drug Promotion (OPDP).
The FDA's Office of Prescription Drug Promotion (OPDP)--formerly known as the Division of Drug Marketing, Advertising and Communications (DDMAC)--monitors and reviews pharmaceutical product labeling, advertising, and promotional materials to ensure advertisements are truthful, balanced, and accurately communicated.
In 2016, the Food and Drug Administration s Office of Prescription Drug Promotion received 97,252 promotional materials that drug companies submitted for review, compared with 34,182 in 1997, but violation letters for prescription drug advertising decreased from 156 to 11.
A statement by the Baghdad Operations Command said that a terrorist accused was arrested in Al-Furat district, and a suspect was arrested in Al-Amil neighborhood and a third accused of forgery in Al-Nasr and Al-Salam area in Abu Ghraib district, west of Baghdad, and another accused of drug promotion in Al-Rasheed area south of it.
The president raised the issue of drug promotion, especially in universities, schools and nightclubs, and asked the concerned security forces to take the necessary measures to combat this phenomenon which negatively affects the country's youth.
There are many reasons that lead to drug promotion and abuse such as weak religious understanding and family disintegration.
Food and Drug Administration issued two Federal Register notices related to prescription drug promotion from the FDA Center for Drug Evaluation and Research's Office of Prescription Drug Promotion.
We have no commercial aspect in organizing such meeting and you won't see any product name or drug promotion on this occasion.
Col Hareb praised his officers' work to curb the drug trade and urged the public to alert police if they suspected any person is involved in drug promotion or sale.
It begins with a heading of Health Policy Brief followed by the title, Off-Label Drug Promotion. In the first paragraph we read,
According to the listing from the FDA, "the objective of this research is to test whether a link to prescription drug risk information can effectively convey the risks associated with a drug when benefit claims about that drug are made within character-space-limited communications used in prescription drug promotion."

Full browser ?